Healthcare -
Biotechnology - NASDAQ - US
$ 0.421
-4.33 %
$ 124 M
Market Cap
-0.32
P/E
LYEL - REVENUE
Revenue LYEL - Lyell Immunopharma, Inc.
61 K
LAST VALUE
-97.32%
2 YEAR CAGR
-37.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR